PDL BioPharma Top Insiders
PDL BioPharma employs about 109 people. The company is managed by 17 executives with a total tenure of roughly 133 years, averaging almost 7.0 years of service per executive, having 6.41 employees per reported executive. Assessment of PDL BioPharma's management performance can provide insight into the firm performance.
| John McLaughlin CEO President CEO, Director |
| Jill Jene President Vice President Business Development |
PDL |
PDL BioPharma Management Team Effectiveness
The company has return on total asset (ROA) of (4.1) % which means that it has lost $4.1 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (7.36) %, meaning that it created substantial loss on money invested by shareholders. PDL BioPharma's management efficiency ratios could be used to measure how well PDL BioPharma manages its routine affairs as well as how well it operates its assets and liabilities.PDL BioPharma Workforce Comparison
PDL BioPharma is considered to be number one stock in number of employees category among related companies. The total workforce of Biotechnology industry is at this time estimated at about 84,366. PDL BioPharma adds roughly 109 in number of employees claiming only tiny portion of stocks in Biotechnology industry.
PDL BioPharma Notable Stakeholders
A PDL BioPharma stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as PDL BioPharma often face trade-offs trying to please all of them. PDL BioPharma's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting PDL BioPharma's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| John McLaughlin | President CEO, Director | Profile | |
| Jill Jene | Vice President Business Development | Profile | |
| Dominique Monnet | President | Profile | |
| Christopher Stone | Vice President General Counsel, Secretary | Profile | |
| Ed Imbrogno | Chief Accounting Officer, Vice President - Finance | Profile | |
| Peter Garcia | CFO and VP | Profile | |
| David Gryska | Independent Director | Profile | |
| Natasha Hernday | Independent Director | Profile | |
| Shlomo Yanai | Independent Director | Profile | |
| Samuel Saks | Director | Profile | |
| Harold Selick | Independent Director | Profile | |
| Paul Sandman | Independent Director | Profile | |
| Paul Edick | Director | Profile | |
| Jody Lindell | Independent Director | Profile | |
| Elizabeth Farrell | Independent Director | Profile | |
| Danny Hart | Deputy General Counsel, Assistant Secretary | Profile | |
| Steffen Pietzke | Chief Accounting Officer, Controller | Profile |
PDL BioPharma Workforce Analysis
Traditionally, organizations such as PDL BioPharma use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare PDL BioPharma within its industry.PDL BioPharma Manpower Efficiency
Return on PDL BioPharma Manpower
| Revenue Per Employee | 254.7K | |
| Revenue Per Executive | 1.6M | |
| Net Loss Per Employee | 359.4K | |
| Net Loss Per Executive | 2.3M | |
| Working Capital Per Employee | 2.3M | |
| Working Capital Per Executive | 14.5M |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Other Consideration for investing in PDL Stock
If you are still planning to invest in PDL BioPharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the PDL BioPharma's history and understand the potential risks before investing.
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |